biologic therapy Archives - chatsaudicam.com

Gene Therapy Promising in Leber Hereditary Optic Neuropathy

11/17/2021 biologic therapy, gene therapy

A new gene therapy can significantly improve the visual acuity of people with Leber hereditary optic neuropathy (LHON), researchers say.

Health News

Many Patients, Doctors Unaware of Advancements in Cancer Care

09/30/2021 biologic therapy, Cancer, malig

Many patients with cancer, as well as doctors in fields other than oncology, are unware of just how much progress

Health News

Flurry of Cancer Drug Endorsements From EU Panel

09/21/2021 antineoplasti, biologic therapy

Three new cancer drugs have been recommended for approval in Europe, as well as new indications for two already marketed

Health News

AIDS Virus Used in Gene Therapy to Fix ‘Bubble Baby’ Disease

05/11/2021 biologic therapy, chi, children

A gene therapy that makes use of an unlikely helper, the AIDS virus, gave a working immune system to 48

Health News

Despite COVID, Americans Still Help Others With Medical Bills

04/05/2021 antigens, biologic therapy, Cancer, cancer risk, carcinoma, Diabetes Mellitus, elderly/concerns of older adults, financial hardship, financing, geriatrics (elder care), malignant neoplasia, pandemic:, poverty, practice management, salary compensation, social determinants of health, social issues

The number of Americans donating to crowdfunding campaigns for medical bills during 2020 held steady relative to previous years, despite

Health News

Dermatologists Can Help Identify, Predict Immune-Checkpoint Inhibitor Toxicity

03/31/2021 adverse effects, biologic therapy, biologics, Cancer, carcinoma, immunotherapy, malignant melanoma, malignant neoplasia, malignant neoplasm, malignant skin neoplasm, melanoma, patient safety, Psoriasis, Side Effects, skin cancer

NEW YORK (Reuters Health) – Patients on immune-checkpoint inhibitor (ICI) therapy who experience cutaneous immune-related adverse events (cirAEs) may be

Health News

High BMI Tied to Better Overall Survival in Immune Checkpoint Inhibitor-Treated Metastatic RCC

03/15/2021 biologic therapy, biologics, body mass index (bmi); bmi (body mass index), Cancer, cancer (renal cell), cancer of the kidney, carcinoma, genomic medicine, genomics, malignant kidney neoplasm, malignant neoplasia, malignant neoplasm, medicine (genomic), obese, obesity, Precision Medicine, renal cell cancer, renal cell carcinoma (rcc), targeted cancer therapy, targeted therapy

NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma (mRCC) treated with PD-1/PD-L1-based immune checkpoint inhibitors (ICIs),

Health News

Primary Care Clinicians Neglect Hearing Loss, Survey Finds

03/05/2021 age-related hearing loss, antigens, As, biologic therapy, dementia, depression, disability, ENT (ears, financial hardship, geriatrics (elder care), health care quality/access/evaluation, hearing aid, hearing device, hearing impairment, hearing loss, hearing loss (age-related), hearing screening, Michigan:, nose, Otolaryngology, poverty, presbycusis, primary care, social determinants of health, social issues, Throat

Most adults in the United States have not been asked about their hearing by their primary care provider in the

Health News

CAR T-cell Products Shine, Reveal New Insights

02/22/2021 artificial T-cell receptors, biologic therapy, bmt, bone marrow transplantation, CAR T, chimeric antigen receptor T-cell therapy, chimeric antigen receptors, chimeric immunoreceptors, chimeric T-cell receptors, diffuse large cell lymphoma, Europe, European, Hematology, Lymphoma, malignant lymphoma, non-hodgkin's lymph, Precision Medicine, t cell, transplantation (bone marrow)

Real-world experience with chimeric antigen receptor (CAR) T-cell therapies for large B-cell lymphomas compares favorably with experience in commercial and

Health News

Ustekinumab Works Well in Ulcerative Colitis in the General Population

02/19/2021 biologic therapy, biologics, cetuximab, colitis, IBD, Inflammatory Bowel Disease, inflammatory bowel disease (ibd), Monoclonal Antibody, rituximab, Ulcerative Colitis

NEW YORK (Reuters Health) – The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative